ENGLEWOOD, Colo.--(BUSINESS WIRE)--Inhibiton Therapeutics, Inc. (OTCBB:IHBT) announced today that its company information would be made available via Standard & Poor’s Corporation Records Listing Program. As part of the program, a full description of Inhibiton Therapeutics, Inc. will be published in the Daily News Section of Standard Corporation Records, a recognized securities manual for secondary trading in approximately 38 states under the Blue Sky Laws. Standard Corporation Records is available in print, CD-ROM, and via the Web at www.netadvantage.standardandpoors.com as well as through numerous electronic vendors.
